Preface.
Acknowledgments.
Biographies.
Contributors.
Regulatory Issues, Epidemiology, and Emerging Viruses
1. Current issues in the regulation and approval of antiviral drugs for hepatitis (B.A. Styrt, R. Fleischer , T. Wu, H.M. Jolson).
2. Molecular and serum epidemiology o f HBV and HCV infection and the impact of antiviral agents in China (Xue feng Liu, R.F. Schinazi).
3. New viruses and their relations hip to hepatitis (H.J. Alter).
Immunology and Vaccin es
4. Virus-specific CD8+ cell immune responses in a cute and chronic hepatitis B virus infection (G.J.M. Webster, G.M. Dushe iko).
5. Cell-mediated immunity and the outcome of HCV infect ion in chimpanzees (C.M. Walker).
6. Adoptive immune transfe r as a therapeutic approach for persistent hepatitis B virus infection ( D. Shouval).
7. Perspectives in HCV vaccine development (E. Depla).
Viral Hepatitis B and C Infections In Childr en
8. Maternal/fetal/pediatric HBV and HCV infection
Acknowledgments.
Biographies.
Contributors.
Regulatory Issues, Epidemiology, and Emerging Viruses
1. Current issues in the regulation and approval of antiviral drugs for hepatitis (B.A. Styrt, R. Fleischer , T. Wu, H.M. Jolson).
2. Molecular and serum epidemiology o f HBV and HCV infection and the impact of antiviral agents in China (Xue feng Liu, R.F. Schinazi).
3. New viruses and their relations hip to hepatitis (H.J. Alter).
Immunology and Vaccin es
4. Virus-specific CD8+ cell immune responses in a cute and chronic hepatitis B virus infection (G.J.M. Webster, G.M. Dushe iko).
5. Cell-mediated immunity and the outcome of HCV infect ion in chimpanzees (C.M. Walker).
6. Adoptive immune transfe r as a therapeutic approach for persistent hepatitis B virus infection ( D. Shouval).
7. Perspectives in HCV vaccine development (E. Depla).
Viral Hepatitis B and C Infections In Childr en
8. Maternal/fetal/pediatric HBV and HCV infection
Share This Book: